This study consisted of 33 760 men from the Cohort of Swedish Men (COSM), a prospective study of men living in the Västmanland and Örebro counties in central Sweden. The cohort recruitment,
E pidemiological studies have generally found that, compared with no alcohol intake, light-to-moderate consumption is associated with a lower risk of coronary heart disease morbidity and mortality among adults. 1, 2 Heavy alcohol intake is associated with a higher rate of heart failure (HF), likely via alcohol-associated cardiomyopathy, 3-5 but moderate consumption (≤2 drinks per day for men and ≤1 drink per day for women) may be associated with a lower rate of incident HF.
Clinical Perspective on p 427
Several prospective cohort studies from the United States have shown that, compared with nondrinkers, light-to-moderate alcohol consumption is associated with a lower rate of incident HF, [6] [7] [8] [9] [10] [11] [12] with a meta-analysis 13 reporting that the rate of incident HF is 15% (95% confidence interval, 7%-22%) lower among those who drink <14 drinks per week than among nondrinkers. However, several prior studies did not distinguish between lifelong abstainers and former drinkers [6] [7] [8] [9] 14 who may have quit because of comorbidities, such as alcoholism or other illness, and may be at higher risk of developing HF. In addition, only 3 of these studies assessed the impact of different beverage types. 6, 10, 12 Therefore, we examined whether incident HF hospitalization or mortality is associated with total alcohol consumption or consumption of beer, wine, or spirits among a large population-based cohort of Swedish men followed for ≤14 years. characteristics, and study methods have previously been described. 15 Starting in autumn 1997, a questionnaire about demographics, behavioral and anthropometric factors, and food and beverage intake was sent to men residing in these counties who were aged 45 to 79 years and 48 850 responded. We excluded participants who did not provide or provided incorrect national identification numbers, who had blank questionnaires, or who had previous diagnosis of cancer (other than nonmelanoma skin cancer; n=2944). In addition, we excluded participants with missing or implausible energy intake (>3 SD from the natural log-transformed mean, n=558); missing data on more than half of the food and beverage items (n=4053); missing data on body mass index (BMI; n=1737), or no information on alcohol consumption (n=132). We excluded former drinkers (n=923) because some of these individuals might have stopped drinking in response to underlying health conditions.
In addition to excluding participants with a history of HF (n=869) at baseline, we excluded participants with a history of myocardial infarction (MI; n=1608) or diabetes mellitus (n=2266) at baseline, because they might have received dietary counseling to change their alcohol intake. HF and MI history were determined via inpatient register linkage; diabetes mellitus history was assessed by self-report and inpatient register linkage. The Regional Ethical Review Board at Karolinska Institute (Stockholm, Sweden) approved the study. Consent was implied by completion and return of the self-administered questionnaire.
Assessment of Alcohol Intake and Diet
In 1997, participants received a 96-item self-administered food frequency questionnaire (FFQ) asking about food and beverage consumption over the past year. 16 Men were asked to report if they never drank alcohol, if they had quit drinking alcohol, or if they regularly drink at least some alcohol. For current drinkers, participants reported how frequently they consumed beer (2.8% alcohol), strong beer (4.5% alcohol), wine, fortified wine (>18% alcohol), and liquor (40% alcohol) during the past year. For each type of alcohol, there were 9 prespecified frequency options ranging from never to ≥3× per day. In addition, participants reported how many glasses of light beer (1.8% alcohol) they drank per day or per week during the past year.
The nutrient intake from foods and beverages was calculated by multiplying the frequency of consumption by nutrient composition data from the Swedish National Food Administration by age-specific portion sizes determined using weighted diet records. To estimate beverage-specific alcohol intake (g ethanol/d), we multiplied participant-reported frequency of consumption by alcohol composition data and age-specific drink sizes, as previously described in a similar cohort of Swedish women. 17 To estimate total alcohol intake (g/d), we then summed over each type of alcohol. We defined 1 serving of alcohol as 13 g of alcohol and estimated the average number of standard alcoholic drinks per week. If a current drinker reported information about consumption of at least 1, but not all, types of alcohol, we assumed he never drank the alcohol type(s) with missing information, as suggested in prior work. 18 In a validation study of an FFQ similar to that used in the COSM, 19 248 men from the study area randomly selected from the Swedish Population Register completed an FFQ twice 1 year apart and 14 24hour recall interviews during the year between the first and second FFQ. The Spearman correlation coefficient between the 24-hour recall interviews and the first FFQ estimate of alcohol intake was 0.81.
Assessment of Other Covariates
We used the inpatient register to obtain information on history of MI at baseline, and we classified participants as having diabetes mellitus at baseline via either self-report or a diagnosis of diabetes mellitus recorded on the inpatient register. We computed total physical activity in metabolic equivalents in hours per day based on questions about occupational physical activity, exercise, and sedentary behavior. 20 We calculated BMI as weight in kilograms divided by height in meters squared (both self-reported). The questionnaire also included questions about education (less than high school, high school, university), cigarette smoking (current, past, never), marital status (single, married/living with someone, divorced, widower), family history of MI before age 60 (yes, no), history of hypertension (yes, no), and history of high cholesterol (yes, no). We computed a component score for consistency of diet with the Dietary Approaches to Stop Hypertension (DASH) diet, with higher scores indicative of higher diet quality. 16 Men who were in the highest quintile for fruits, vegetables, nuts and legumes, low-fat dairy, and whole grains received a score of 5, whereas those in the lowest quintile received a score of 1; men in the highest quintile for intake of sodium, sweetened beverages, and red and processed meats received a score of 1. We calculated the overall DASH score as the sum of the component scores.
Follow-Up and Ascertainment of HF
Participants contributed person-time from January 1, 1998, until the earliest of December 31, 2011, date of death due to causes other than HF, date of first HF hospitalization, or HF mortality. If a participant died of a non-HF cause, his follow-up time was censored. We followed patients through record linkage to Swedish inpatient and cause-ofdeath registers. The inpatient register includes >99% of inpatient care in Sweden. 21 Hospitalization for or death from HF was defined as code 428 from the International Classification of Diseases, Ninth Edition or codes I50 or I11.0 from the International Classification of Diseases, Tenth Edition. We included the first hospitalizations or deaths with HF as the primary or secondary diagnosis and only the first HF event in the register for each individual. Among individuals with HF as a primary diagnosis (first position) in the Swedish inpatient register, 95% had HF confirmed by medical record review using European Society of Cardiology criteria; among individuals with HF as a secondary (second position) diagnosis, 76% had confirmed HF diagnosis. 22
Statistical Analyses
We categorized total alcohol intake as never drinker and into the following categories of standard drinks per week: <0.5, 0.5 to <1, 1 to <7, 7 to <14, 14 to <21, and ≥21. We reported baseline characteristics by category of alcohol intake as mean±SD or as counts with proportions for continuous and categorical characteristics, respectively. We used Cox proportional hazards models to estimate multivariableadjusted incidence rate ratios with corresponding 95% confidence intervals for the rate of HF incidence among men who consumed alcohol compared with never drinkers. We tested for a quadratic trend by assigning each participant within a category the median drinks per week within that category. We ran a model with this variable and the squared value of this term as continuous predictors and determined the statistical significance of the squared term. We tested for violations of the proportional hazards model by including the product of alcohol intake and the natural log of survival time and did not find evidence of violations.
We chose covariates that we considered to be potential confounders because of their association with both alcohol intake and HF occurrence. In the first model, we allowed the baseline rate to vary by age. In the second model, we additionally adjusted for total energy intake (linear term), education (less than high school, high school, university), BMI (linear term), cigarette smoking (current, past, never), marital status (single, married/living with someone, divorced, widower), and component score for consistency with DASH diet (quartiles). 16 In secondary analyses, we evaluated the association between HF incidence and each alcoholic beverage type and mutually adjusted for the 2 other beverage types. The referent group for each beverage type was nondrinker of that specific beverage. We conducted tests for quadratic trends to examine the statistical significance of the pattern of association for each alcohol type and HF risk. We performed several sensitivity analyses. First, we conducted an analysis using Markov chain Monte Carlo-imputed data for BMI (n=1415, 4.0%) and physical activity (n=6907, 19.6%) 23, 24 and evaluated whether further adjusting for physical activity, family history of MI before age 60, history of hypertension, and history of high cholesterol would alter results. Second, we estimated the fully adjusted model of total alcohol intake using a proportional subdistribution hazards model to account for competing risks of non-HF death. 25 Third, we tested whether the association between alcohol consumption and HF differed by self-reported history of hypertension, history of high cholesterol, or current smoking using likelihood ratio tests. Fourth, because unrecognized illness may influence alcohol consumption at baseline, we conducted a sensitivity analysis excluding the first 2 years of followup. Finally, because some of the cases with HF as secondary diagnosis might have been false positives, we conducted analyses where we defined cases of HF only based on a primary diagnosis. We performed statistical analyses using SAS version 9.3 (Cary, NC) and used the stcrreg command in Stata version 12 (Statacorp, College Station, TX) for the competing risks model. For all analyses, 2-sided P<0.05 was considered to be statistically significant.
Results
Over 14 years of follow-up of 33 760 men in the study, 2916 were hospitalized for HF for the first time (n=2139) or died of HF (n=777), corresponding to a baseline rate of 67.8 HF cases per 10 000 person-years. Most of the study participants reported drinking 1 to <7 alcoholic drinks per week. Compared with never drinkers, men who reported consuming an average of 7 to <14 drinks per week were on average younger and were more likely to be a current or former smoker and to report history of high cholesterol (Table 1) .
There was a statistically significant quadratic trend, supporting a U-shaped relationship between total alcohol intake and HF (P=0.0004), with a nadir at light-to-moderate alcohol consumption ( Table 2 ). In the analyses by beverage type, we observed suggestions of U-shaped trends between beveragespecific intake and incident HF ( Table 3) .
Results were similar when, in sensitivity analyses, we imputed physical activity and BMI and additionally adjusted for hypertension, high cholesterol, family history of MI, and imputed physical activity. Accounting for competing risks did not substantially alter the results. In analyses excluding the first 2 years of follow-up, results did not differ materially. The association between alcohol intake and HF did not differ by self-reported history of hypertension (P interaction=0.70), smoking status (P interaction=0.37), or self-reported high cholesterol (P interaction=0.08). When we defined HF as those cases with a primary diagnosis of HF, the results were similar.
Discussion
In this large prospective cohort study, there was a U-shaped relationship between total alcohol intake and incident HF, with a nadir at light-to-moderate alcohol intake. When we examined the association separately for beer, wine, and spirits and mutually adjusted for other beverage types, we found suggestion of a U-shaped trend for beer, wine, and spirits. Although wine and spirits no longer appeared protective above 7 drinks per week, beer appeared potentially protective for 7 to 14 drinks per week. This may be because of drinking patterns; nonbeer drinkers included a higher proportion of never drinkers than did the nonwine or nonspirit drinkers. In addition, men in the highest categories of wine (≥14 drinks per week) or spirits (≥7 drinks per week) consumed fairly high levels of total alcohol, with medians of 26.9 and 20 standard drinks per week, respectively. There are several potential mechanisms that may explain how light-to-moderate alcohol intake is associated with a lower rate of HF. Moderate alcohol consumption is associated with a lower rate of MI, 26 a key risk factor for HF. In addition, moderate alcohol intake leads to beneficial effects on several coronary artery disease risk factors. 27 Experimental studies have shown that within weeks, moderate alcohol consumption is associated with increased high-density lipoprotein cholesterol, apolipoprotein A-I, and adiponectin and decreased fibrinogen levels. 27 Type 2 diabetes mellitus is a major risk factor for HF. 28 Some observational studies 29 have shown that moderate alcohol consumption is associated with a lower risk of type 2 diabetes mellitus, and some experimental studies have shown that it lowers insulin levels 30 and increases insulin sensitivity. 30, 31 Our findings are consistent with many, [6] [7] [8] [9] [10] [11] [12] but not all, 14 of the prior studies showing that moderate alcohol intake is associated with a lower rate of incident HF. For example, in a cohort of people aged ≥65 years, 6 participants who reported drinking 21 to 70 ounces of alcohol per day (≈1.5-4 drinks) had a 47% lower rate of incident HF compared with nondrinkers (incidence rate ratio, 0.53; 95% confidence interval, 0.32-0.88). Some prior studies 6-9 did not have information about whether nondrinkers were lifelong abstainers or former drinkers. Therefore, their results may have overestimated the protective benefits of alcohol because some former drinkers might have quit because of comorbidities, such as alcoholism and other illness. Similar to our study, a recent meta-analysis of alcohol and incident HF also found a nonlinear dose-response between alcohol and incident HF. 13 Cox proportional hazards model accounting for age and adjusted for total energy intake (linear term), education (less than high school, high school, university), body mass index (linear term), dietary component score (quartiles), cigarette smoking (current, past, never), and marital status (single, married/ living with someone, divorced, widower). Each model also mutually adjusted for consumption of other 2 beverage types. CI indicates confidence interval.
*Nondrinkers include nonconsumers of alcohol and current alcohol drinkers who reported not consuming the specific beverage of interest (eg, beer). †Among those consuming: ≥14 standard drinks of beer per week, median weekly standard drinks of total alcohol: 21.2, of beer: 17.3; ≥14 standard drinks of wine per week, median weekly standard drinks of total alcohol: 26.9, of wine: 16.2; and ≥7 standard drinks of spirits per week, median weekly standard drinks of total alcohol: 20.0, of spirits: 9.6. In 1 of the studies that examined the association between incident and HF and beer, wine, or spirits, the results were similar for all alcoholic beverage types. 6 In another study, Klatsky et al 10 examined the association between alcohol and HF risk for those with and without known coronary artery disease at the time of HF. Among those without known coronary artery disease, a higher frequency of wine consumption was associated with a lower rate of HF among men but there was no benefit of a higher frequency of consuming beer or liquor. In our study, there was a suggestion of protective benefit of light intake of all alcohol types.
Our study has several limitations. First, although we adjusted for multiple potential confounders, we cannot rule out the possibility of residual or unmeasured confounding. For instance, we were only able to adjust for smoking status as never, former, or current smoker, and we did not have information on pack years or years since quitting. However, because smokers tend to drink more alcohol 32 and they are at a higher risk of HF, 33 confounding by smoking would make alcohol seems less protective. This is in agreement with our results; light-to-moderate alcohol intake appeared more protective in the model that adjusted for smoking than in the ageadjusted model. Second, we used an FFQ that is reproducible and valid, 19 but some individuals tend to under-report alcohol consumption 34 and heavier drinkers are more likely to underreport drinking than are lighter drinkers. Third, most of the participants reported no or moderate consumption, thereby limiting our ability to assess the impact of heavy consumption of incident HF risk. Fourth, although the accuracy of HF diagnosis in Swedish registers has previously been shown to be high, 22 these registers only include HF cases that were hospitalized or died, so these findings might not be applicable to less severe cases. Furthermore, these registers do not include information about HF subtype (eg, systolic or diastolic dysfunction) or pathogenesis.
Our study also has several strengths. Because this is a large, population-based prospective cohort study, concerns about recall bias are minimized. In addition, we were able to exclude former drinkers who may have altered their alcohol consumption in response to underlying health conditions. Finally, the FFQ includes detailed information on consumption of beer, wine, and spirits and is reproducible and valid. 19 In summary, in this large prospective cohort study of middle-aged and elderly Swedish men, there was a U-shaped relationship between alcohol consumption and incident HF. Light-to-moderate, but not heavy, alcohol intake was associated with a lower rate of HF hospitalization or death. Because moderate alcohol consumption also carries potential risks, such as an increased risk of cancer 35 and injury, 36 public health messages about the potential cardioprotective consequences of alcohol consumption should take into consideration both risks and benefits. Additional work is necessary to examine whether drinking patterns influence the relationship between alcohol consumption and incident HF.
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